首页> 外文会议>International Conference on Bioinformatics and Systems Biology >Identijication of potential inhibitors for identified novel drug targets of Aspergillus fumigatus
【24h】

Identijication of potential inhibitors for identified novel drug targets of Aspergillus fumigatus

机译:鉴定鉴定鉴定新型药物靶向曲霉病的潜在抑制剂

获取原文

摘要

Aspergillosis is the most common mold infection worldwide and Aspergillus fumigatus is the most common etiological agent being responsible for approximately 90% of human infections. Over the past years, A. fumigatus has become the most prevalent airborne fungal pathogen, causing severe and usually fatal invasive infections in immune compromised hosts in developed countries. Despite the prevalence of life-threatening fungal infections by Aspergillus fumigatus, treatments are restricted to a relatively few antifungal drugs whose use is increasingly challenged by the emergence of drug- resistant fungi and by serious problems of toxicity. An urgent need exists for a novel drug target and the new generation of antifungal drugs with superior safety and efficacy against a broad fungal spectrum. In this paper, the subtractive genomic approach was used to identify novel drug target for Aspergillus fumigatus. Out of 51,215 protein in Aspergillus fumigatus only 3,805 protein remains after excluding homologous protein. In this paper, we finally find out two novel drug target after performing modelling and then identified its potential inhibitor with the help of screening and docking.
机译:曲霉病是最常见的霉菌感染全世界和烟曲霉是最常见的病因学试剂,负责人感染的约90%。在过去几年里,烟曲霉已成为最普遍的机载真菌病原体,导致在发达国家免疫受损主机严重,通常是致命的侵袭性感染。尽管由烟曲霉威胁生命的真菌感染的患病率,治疗仅限于相对较少的抗真菌药物,它的使用越来越受到抗药菌的出现和毒性的严重问题的挑战。迫切需要一种新的药物靶标和新一代抗真菌药物具有抗广谱真菌谱优越的安全性和有效性。在本文中,使用了减色基因组方法鉴定新的药物靶标烟曲霉。出烟曲霉51215蛋白质仅剔除同源蛋白后,3805具蛋白质遗体。在本文中,我们终于发现了两个新的药物靶标进行建模后,然后确定它与筛选和对接的帮助潜在抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号